CD4 and neoplasm: The presentation of antigens by HSPCs to CD4<sup>+</sup> T cells biased HSPC lineages toward myelopoiesis and polarized CD4<sup>+</sup> T cells to regulatory T cells, culminating in tumor immunotolerance.